NCT07108907 Outcome Registry and Assessment of New Edge-to-Edge Repair
| NCT ID | NCT07108907 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abby Geerlings |
| Condition | Mitral Regurgitation |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-07-10 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-07-10 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the long-term effects of Edge-tot-edge repair of all the patients of AmsterdamUMC, to treat their Mitral regurgitation (MR). The main question it aims to answer is: The patient selection process could be optimized. Participants are already receiving edge-to-edge repair as part of their standard medical care and will additionally complete quality-of-life survey questions.
Eligibility Criteria
Eligibility Criteria Inclusion Criteria: * Age ≥ 18 years * Accepted for M-TEER (Minimally Invasive Transcatheter Edge-to-Edge Repair) procedure Exclusion Criteria: \- Unable to complete the questionnaires
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07108907 clinical trial?
This trial is open to participants of all sexes, studying Mitral Regurgitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07108907 currently recruiting?
Yes, NCT07108907 is actively recruiting participants. Contact the research team at a.e.geerlings@amsterdamumc.nl for enrollment information.
Where is the NCT07108907 trial being conducted?
This trial is being conducted at Amsterdam, Netherlands.
Who is sponsoring the NCT07108907 clinical trial?
NCT07108907 is sponsored by Abby Geerlings. The trial plans to enroll 300 participants.